{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:54:30Z","timestamp":1780084470860,"version":"3.54.0"},"reference-count":73,"publisher":"Baishideng Publishing Group Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4254\/wjh.v6.i6.410","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T01:52:51Z","timestamp":1404352371000},"page":"410","source":"Crossref","is-referenced-by-count":11,"title":["Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids"],"prefix":"10.4254","volume":"6","author":[{"given":"Marta Casal","family":"Moura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2179-3"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23584"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.09.009"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000329805"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.08.013"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.08.003"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.037"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.3301"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.1035"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.08.004"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12381"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-011-0421-y"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1586\/egh.13.21"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.11.002"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.235259"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.04.053"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.01.009"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23840"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608895"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i8.934"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Autoimmune hepatitis: focusing on treatments other than steroids. Can J Gastroenterol 2012;26:615-620.","DOI":"10.1155\/2012\/512132"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23924"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-009-0170-7"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.3"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050408"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Special reports: autoimmune hepatitis. Curr Treat Options Gastroenterol 1999;2:423-436.","DOI":"10.1007\/s11938-999-0033-2"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.009"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00214-3"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12223"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Danielsson A, Prytz H. Oral budesonide for treatment of autoimmune chronic active hepatitis. Aliment Pharmacol Ther 1994;8:585-590.","DOI":"10.1111\/j.1365-2036.1994.tb00334.x"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.09.011"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01904.x"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2151-2"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80271-8"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Devlin SM, Swain MG, Urbanski SJ, Burak KW. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can J Gastroenterol 2004;18:321-326.","DOI":"10.1155\/2004\/504591"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2003.10.017"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01107.x"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Czaja AJ, Carpenter HA. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease. J Clin Gastroenterol 2005;39:819-825.","DOI":"10.1097\/01.mcg.0000177260.72692.e8"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.02.030"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.04.006"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02180.x"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0632-0"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, Taheri H, Kamalian N, Sotoudeh M. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001;46:1321-1327.","DOI":"10.1023\/A:1010683817344"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Fernandes NF, Redeker AG, Vierling JM, Villamil FG, Fong TL. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastroenterol 1999;94:241-248.","DOI":"10.1111\/j.1572-0241.1999.00807.x"},{"key":"ref46","unstructured":"Van Thiel DH, Wright H, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, McMichael J, Irish W, Starzl TE. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995;90:771-776."},{"key":"ref47","unstructured":"Heneghan MA, Rizzi P, McFarlane IG, Portmann B, Harrison PM. Low dose tacrolimus as treatment of severe autoimmune hepatitis: potential role in remission induction. Gut 1999;44:A61."},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol 2004;38:805-809.","DOI":"10.1097\/01.mcg.0000139050.67178.be"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Larsen FS, Vainer B, Eefsen M, Bjerring PN, Adel Hansen B. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol 2007;13:3232-3236.","DOI":"10.3748\/wjg.v13.i23.3232"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1159\/000322693"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.010"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80128-1"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300603"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-1122-8"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1586\/egh.12.38"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.02.024"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04727.x"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Sharzehi K, Huang MA, Schreibman IR, Brown KA. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy. Can J Gastroenterol 2010;24:588-592.","DOI":"10.1155\/2010\/891252"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.12.032"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.1999.00015.x"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.3.459"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Alvarez F, Ciocca M, Ca\u00f1ero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M, Gonzalez T, Jara-Vega P, Camarena C, Brochu P. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999;30:222-227.","DOI":"10.1016\/S0168-8278(99)80065-8"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994;83:435-445.","DOI":"10.1182\/blood.V83.2.435.435"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.08.007"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1177\/106689690301100414"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Burak KW, Swain MG, Santodomingo-Garzon T, Lee SS, Urbanski SJ, Aspinall AI, Coffin CS, Myers RP. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. Can J Gastroenterol 2013;27:273-280.","DOI":"10.1155\/2013\/512624"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199501000-00005"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 1999;117:645-652.","DOI":"10.1016\/S0016-5085(99)70458-0"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999;30:851-856.","DOI":"10.1002\/hep.510300412"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.10.38\/ajg.2009.433"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"O&rsquo;Steen WK, Shear CR, Anderson KV. Extraocular muscle degeneration and regeneration after exposure of rats to incandescent radiant energy. J Cell Sci 1975;18:157-177.","DOI":"10.1242\/jcs.18.1.157"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06579.x"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-009-9155-9"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v6\/i6\/410.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T10:51:59Z","timestamp":1649587919000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v6\/i6\/410.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v6.i6.410","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}